BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2508644)

  • 21. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
    Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
    J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of immunoglobulin classes and subclasses in anti-Rh (D) antibodies.
    Mattila PS; Seppälä IJ; Eklund J; Mäkelä O
    Vox Sang; 1985; 48(6):350-6. PubMed ID: 3925632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticentromere antibody in primary biliary cirrhosis.
    Bernstein RM; Callender ME; Neuberger JM; Hughes GR; Williams R
    Ann Rheum Dis; 1982 Dec; 41(6):612-4. PubMed ID: 7149799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis.
    McHugh NJ; James IE; Fairburn K; Maddison PJ
    Clin Exp Immunol; 1990 Aug; 81(2):244-9. PubMed ID: 2117509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of anticentromere antibodies using recombinant human CENP-A protein.
    Sun D; Martinez A; Sullivan KF; Sharp GC; Hoch SO
    Arthritis Rheum; 1996 May; 39(5):863-7. PubMed ID: 8639184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma.
    Ford AL; Kurien BT; Harley JB; Scofield RH
    J Rheumatol; 1998 Jul; 25(7):1419-24. PubMed ID: 9676778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human anti-centromere sera recognise a 19.5 kD non-histone chromosomal protein from HeLa cells.
    Guldner HH; Lakomek HJ; Bautz FA
    Clin Exp Immunol; 1984 Oct; 58(1):13-20. PubMed ID: 6383665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
    Johanet C; Agostini MM; Vayssairat M; Abuaf N
    Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.
    Vázquez-Abad D; Wallace S; Senécal JL; Joyal F; Roussin A; Earnshaw WC; Rothfield N
    Arthritis Rheum; 1994 Feb; 37(2):248-52. PubMed ID: 8129780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.
    Persselin JE; Stevens RH
    J Clin Invest; 1985 Aug; 76(2):723-30. PubMed ID: 3928684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isotypy of serum monoclonal immunoglobulins in human immunodeficiency virus-infected adults.
    Briault S; Courtois-Capella M; Duarte F; Aucouturier P; Preud'Homme JL
    Clin Exp Immunol; 1988 Nov; 74(2):182-4. PubMed ID: 3147151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
    Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
    Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.
    Eisenberg RA; Craven SY; Cohen PL
    J Immunol; 1987 Aug; 139(3):728-33. PubMed ID: 3474277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
    Muro Y; Sugimoto K; Okazaki T; Ohashi M
    J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.
    Ueki A; Isozaki Y; Tomokuni A; Hatayama T; Ueki H; Kusaka M; Shiwa M; Arikuni H; Takeshita T; Morimoto K
    Clin Exp Immunol; 2002 Sep; 129(3):556-61. PubMed ID: 12197899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticentromere antibodies: clinical and biological significance.
    Fritzler MJ; Ayer LM
    J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA; Rice JR; Bembe ML; Barada FA
    Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype.
    Fritzler MJ; Hudson M; Choi MY; Mahler M; Wang M; Bentow C; Milo J; Baron M;
    Autoimmun Rev; 2018 Mar; 17(3):267-275. PubMed ID: 29369808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.